FELINE LEUKEMIA

PURE PROTECTION AGAINST ONE OF THE DEADLIEST FELINE DISEASES

FELINE LEUKEMIA IS ONE OF THE MOST SIGNIFICANT CAUSES OF ILLNESS AND DEATH AMONG CATS. 1

Feline Leukemia Virus (FeLV)-infected cats are 62x more likely to develop lymphoma than non infected cats and can contribute to other infectious diseases or anemia by suppressing the immune system and bone marrow production.1

Cats are at risk of becoming infected with FeLV when they are exposed to persistently infected cats; risk is highest in cats that are intact and have outdoor access.2

THERE IS NO CURE

Fortunately, there’s something you can do.  A simple vaccination is the best way to help protect your cat against the Feline Leukemia virus.

ALL CATS ARE AT RISK

All it takes to spread Feline Leukemia Virus (FeLV) is contact with bodily fluids from an infected animal.


Feline Leukemia is especially dangerous to young cats.1 Kittens can contract the disease from their mothers while nursing or still in the womb.1

ADVANCED PROTECTION. PURE POTENCY.

Your veterinarian is committed to helping you make the right choices for your cat’s health. To give your cats the protection they need, this clinic recommends vaccination with PUREVAX® Recombinant FeLV vaccine.

It’s proven to be highly effective against the feline leukemia virus. PUREVAX® Recombinant FeLV vaccine also protects without the need for adjuvants, helping to reduce potential risks to feline patients, such as injection site reactions and chronic inflammation.3,4

PEACE OF MIND

PUREVAX® Recombinant FeLV vaccine offers the protection your cat needs— without the use of adjuvants.

*Impact Vet YTD May 2018, includes the whole range of Purevax Vaccines

  1. Hartmann, K. Clinical Aspects of Feline Retroviruses: A Review. Viruses. 2012;4:2684-2710
  2. Burling, AN., Levy, JK., Scott, HM et al. Seroprevalences of feline leukemia virus and feline immunodeficiency virus infection in cats in the United States and Canada and risk factors for seropositivity. JAVMA. 2017;251(2):187-194.
  3. Poulet H, Minke J, Pardo C, et al. Development and registration of recombinant veterinary vaccines: The example of the canarypox vector platform. Vaccine. 2007;25:5606–5612.
  4. Day MJ, Schoon HA, Magnol JP, et al. A kinetic study of histopathological changes in the subcutis of cats injected with non-adjuvanted multi-component vaccines. Vaccine. 2007;25:4073-4084.

Related Article

Keeping Your Cat Healthy Read Now

previous arrow
next arrow
Slider
Print Friendly, PDF & Email
error: Content is protected !!